7 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Impairment #CKD #Table
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
PDE5 inhibitors ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Summary of Pharmacology ... Proposed COVID-19 Treatments ... #Pharmacology ... #Dosing #Table ... Coronavirus #SARSCOV2 #Medications
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
anticoagulation in North America ... clearance (calculated using ... interruption per treatment ... table ... #pharmacology #
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
• Nephrogenic diabetes ... DDAVP) • Central diabetes ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology ... #Medications #Table
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... recommendations for the treatment ... #Pharmacology #
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
Potassium Binder INDICATION ... : Treatment of Hyperkalemia ... oral suspension DOSING ... with CKD, HF, or diabetes ... ACE inhibitors,